Empirical anti-TNF dose intensification in inflammatory bowel disease: real-world outcomes from a resource-limited setting

Authors

  • Alex Arenas Unit of Gastroenterology. Internal Medicine Department. Faculty of Medicine. Clínica Alemana - Universidad del Desarrollo; Chile
  • Diego Ruedi Unit of Gastroenterology. Internal Medicine Department. Faculty of Medicine. Clínica Alemana - Universidad del Desarrollo; Chile
  • Gustavo Walsen Unit of Gastroenterology. Internal Medicine Department. Faculty of Medicine. Clínica Alemana - Universidad del Desarrollo; Chile
  • Patricio Ibañez Unit of Gastroenterology. Internal Medicine Department. Faculty of Medicine. Clínica Alemana - Universidad del Desarrollo; Chile

DOI:

https://doi.org/10.15403/jgld-6950

Downloads

Published

2026-09-26

How to Cite

1.
Arenas A, Ruedi D, Walsen G, Ibañez P. Empirical anti-TNF dose intensification in inflammatory bowel disease: real-world outcomes from a resource-limited setting. JGLD [Internet]. 2026 Sep. 26 [cited 2026 Oct. 9];35(3):499-500. Available from: https://jgld.ro/jgld/index.php/jgld/article/view/6950

Issue

Vol. 35 No. 3: September 2026

Section

Letters

License

Copyright (c) 2026 Journal of Gastrointestinal and Liver Diseases

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.